DPP4 and diabetes mellitus: Therefore, the use of DPP IV inhibitors may be ideal in patients with Tac-induced diabetes; however, it remains unclear whether the tissue-protective effects of DPP IV inhibitors are also effective in Tac-induced pancreatic islet cell injury.